Qui­et end for flashy up­start, the PD-(L)1 reck­on­ing that was­n't, Big Phar­ma's Covid-19 year, and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

I was some­what de­tached from dai­ly news this week to work on a spe­cial fea­ture, which gave me a spe­cial per­spec­tive on the ex­cel­lent re­port­ing from my col­leagues. The team is grow­ing and it shows. Big thanks to all of our read­ers for mak­ing it pos­si­ble.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.